Pharming Group NV
AEX:PHARM

Watchlist Manager

Pharming Group NV

AEX:PHARM

Watchlist

Dividends

Price: 0.877 EUR -0.4% Market Closed

Market Cap: 594.9m EUR

Have any thoughts about
Pharming Group NV?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 0.877 EUR

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

PHARM Alert

Pharming Group NV

0.877

-0.0035 (-0.4%)

52 Week Range	0.6545 1.199
Price Target

We'll email you a reminder when the closing price reaches EUR.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Pharming Group NV

What unique competitive advantages
does Pharming Group NV hold over its rivals?

What risks and challenges
does Pharming Group NV face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Pharming Group NV.

What unique competitive advantages
does Pharming Group NV hold over its rivals?

What risks and challenges
does Pharming Group NV face in the near future?

Has there been any significant insider trading activity
in Pharming Group NV recently?

Summarize the latest earnings call
of Pharming Group NV.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Pharming Group NV.

Provide P/S
for Pharming Group NV.

Provide P/E
for Pharming Group NV.

Provide P/OCF
for Pharming Group NV.

Provide P/FCFE
for Pharming Group NV.

Provide P/B
for Pharming Group NV.

Provide EV/S
for Pharming Group NV.

Provide EV/GP
for Pharming Group NV.

Provide EV/EBITDA
for Pharming Group NV.

Provide EV/EBIT
for Pharming Group NV.

Provide EV/OCF
for Pharming Group NV.

Provide EV/FCFF
for Pharming Group NV.

Provide EV/IC
for Pharming Group NV.

Show me price targets
for Pharming Group NV made by professional analysts.

What are the Revenue projections
for Pharming Group NV?

How accurate were the past Revenue estimates
for Pharming Group NV?

What are the Net Income projections
for Pharming Group NV?

How accurate were the past Net Income estimates
for Pharming Group NV?

What are the EPS projections
for Pharming Group NV?

How accurate were the past EPS estimates
for Pharming Group NV?

What are the EBIT projections
for Pharming Group NV?

How accurate were the past EBIT estimates
for Pharming Group NV?

Compare the revenue forecasts
for Pharming Group NV with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Pharming Group NV and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Pharming Group NV against its competitors.

Analyze the profit margins
(gross, operating, and net) of Pharming Group NV compared to its peers.

Compare the P/E ratios
of Pharming Group NV against its peers.

Discuss the investment returns and shareholder value creation
comparing Pharming Group NV with its peers.

Analyze the financial leverage
of Pharming Group NV compared to its main competitors.

Show all profitability ratios
for Pharming Group NV.

Provide ROE
for Pharming Group NV.

Provide ROA
for Pharming Group NV.

Provide ROIC
for Pharming Group NV.

Provide ROCE
for Pharming Group NV.

Provide Gross Margin
for Pharming Group NV.

Provide Operating Margin
for Pharming Group NV.

Provide Net Margin
for Pharming Group NV.

Provide FCF Margin
for Pharming Group NV.

Show all solvency ratios
for Pharming Group NV.

Provide D/E Ratio
for Pharming Group NV.

Provide D/A Ratio
for Pharming Group NV.

Provide Interest Coverage Ratio
for Pharming Group NV.

Provide Altman Z-Score Ratio
for Pharming Group NV.

Provide Quick Ratio
for Pharming Group NV.

Provide Current Ratio
for Pharming Group NV.

Provide Cash Ratio
for Pharming Group NV.

What is the historical Revenue growth
over the last 5 years for Pharming Group NV?

What is the historical Net Income growth
over the last 5 years for Pharming Group NV?

What is the current Free Cash Flow
of Pharming Group NV?

Discuss the annual earnings per share (EPS)
trend over the past five years for Pharming Group NV.

Section:

Wall Street
Price Targets

PHARM Price Targets Summary
Pharming Group NV

There are no price targets for PHARM.

PHARM Lowest Forecast

Wall Street Target

Not Available

PHARM Average Forecast

Wall Street Target

Not Available

PHARM Highest Forecast

Wall Street Target

Not Available

Lowest

Price Target

Not Available

Average

Price Target

Not Available

Highest

Price Target

Not Available

Pharming Group NV Competitors:
Price Targets

NANO

Nanobiotix SA

324% Upside

SRZN

Surrozen Inc

184% Upside

KTRA

Kintara Therapeutics Inc

143% Upside

LGND

Ligand Pharmaceuticals Inc

12% Upside

NANO

Nanobiotix SA

324% Upside

SRZN

Surrozen Inc

184% Upside

KTRA

Kintara Therapeutics Inc

143% Upside

LGND

Ligand Pharmaceuticals Inc

12% Upside

CMRX

Chimerix Inc

135% Upside

TWST

Twist Bioscience Corp

14% Upside

REGN

Regeneron Pharmaceuticals Inc

56% Upside

GBIO

Generation Bio Co

500% Upside

Revenue
Forecast

Revenue Estimate
Pharming Group NV

For the last 8 years the compound annual growth rate for Pharming Group NV's revenue is 48%. The projected CAGR for the next 4 years is 15%.

48%

Past Growth

15%

Estimated Growth

Estimates Accuracy

-7%

Average Miss

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Pharming Group NV

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-7%

Average Miss

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Pharming Group NV

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-16%

Average Miss

What are analyst estimates?

What is PHARM's stock price target?

Not Available

PHARM doesn't have any price targets made by Wall Street professionals.

What is Pharming Group NV's Revenue forecast?

Projected CAGR
15%

For the last 8 years the compound annual growth rate for Pharming Group NV's revenue is 48%. The projected CAGR for the next 4 years is 15%.

	Franklin Covey Co NYSE:FC	36.225 USD -0.51%
	Mohawk Industries Inc NYSE:MHK	118.92 USD -0.2%
	Ardmore Shipping Corp NYSE:ASC	11.71 USD 3.54%
	ASGN Inc NYSE:ASGN	83.28 USD -0.7%
	Skyworks Solutions Inc NASDAQ:SWKS	89.27 USD 0.59%
	Weatherford International PLC NASDAQ:WFRD	68.08 USD 1.46%

	Johnson & Johnson NYSE:JNJ	143.71 USD -0.53%
	Bank of America Corp NYSE:BAC	43.41 USD -1.72%
	Mastercard Inc NYSE:MA	524.02 USD -0.77%
	Salesforce Inc NYSE:CRM	339.185 USD -1.3%
	Abbvie Inc NYSE:ABBV	175.6371 USD 0.03%
	Home Depot Inc NYSE:HD	388.89 USD -0.94%

	Arista Networks Inc NYSE:ANET	112.79 USD -0.02%
	Visa Inc NYSE:V	314.825 USD -0.91%
	Texas Pacific Land Corp NYSE:TPL	1 117.345 USD -1.39%
	KLA Corp NASDAQ:KLAC	637.52 USD 1.29%
	Manhattan Associates Inc NASDAQ:MANH	276.005 USD -1.52%
	Pinduoduo Inc NASDAQ:PDD	99.425 USD -0.09%

	Salesforce Inc NYSE:CRM	339.185 USD -1.3%
	Accenture PLC NYSE:ACN	355.91 USD -2.86%
	ServiceNow Inc NYSE:NOW	1 082.71 USD -0.78%
	EOG Resources Inc NYSE:EOG	119.34 USD 0.25%
	Copart Inc NASDAQ:CPRT	58.04 USD -0.31%
	Applied Materials Inc NASDAQ:AMAT	165.38 USD 1.09%

Pharming Group NV
AEX:PHARM

Wall Street
Price Targets

PHARM Price Targets Summary
Pharming Group NV

Revenue
Forecast

Revenue Estimate
Pharming Group NV

Operating Income
Forecast

Operating Income Estimate
Pharming Group NV

Net Income
Forecast

Net Income Estimate
Pharming Group NV

See Also

What is PHARM's stock price target?

Not Available

What is Pharming Group NV's Revenue forecast?

Projected CAGR
15%

Company

Help

Tools

Stocks

Pharming Group NV AEX:PHARM

Wall Street Price Targets

PHARM Price Targets Summary Pharming Group NV

Revenue Forecast

Revenue Estimate Pharming Group NV

Operating Income Forecast

Operating Income Estimate Pharming Group NV

Net Income Forecast

Net Income Estimate Pharming Group NV

See Also

What is PHARM's stock price target? Not Available

What is Pharming Group NV's Revenue forecast? Projected CAGR 15%

Company

Help

Tools

Stocks

Pharming Group NV
AEX:PHARM

Wall Street
Price Targets

PHARM Price Targets Summary
Pharming Group NV

Revenue
Forecast

Revenue Estimate
Pharming Group NV

Operating Income
Forecast

Operating Income Estimate
Pharming Group NV

Net Income
Forecast

Net Income Estimate
Pharming Group NV

What is PHARM's stock price target?

Not Available

What is Pharming Group NV's Revenue forecast?

Projected CAGR
15%